AEPGX
Price
$55.67
Change
+$0.64 (+1.16%)
Updated
Apr 24 closing price
Net Assets
123.11B
BGPTX
Price
$11.30
Change
-$0.00 (-0.00%)
Updated
Apr 24 closing price
Net Assets
192.13M
Ad is loading...

AEPGX vs BGPTX

Header iconAEPGX vs BGPTX Comparison
Open Charts AEPGX vs BGPTXBanner chart's image
American Funds Europacific Growth A
Price$55.67
Change+$0.64 (+1.16%)
VolumeN/A
Net Assets123.11B
Baillie Gifford Developed EAFE All Cap 2
Price$11.30
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets192.13M
AEPGX vs BGPTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPGX vs. BGPTX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and BGPTX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 123B vs. BGPTX (192M). BGPTX pays higher dividends than AEPGX: BGPTX (3.21) vs AEPGX (1.11). AEPGX was incepted earlier than BGPTX: AEPGX (41 years) vs BGPTX (11 years). AEPGX (0.85) is less costly to investors than BGPTX (0.63). AEPGX is a more actively managed with annual turnover of: 30.00 vs. BGPTX (15.00). AEPGX has a lower initial minimum investment than BGPTX: AEPGX (250) vs BGPTX (25000000). AEPGX annual gain was more profitable for investors over the last year : -1.92 vs. BGPTX (-6.98). AEPGX return over 5 years is better than : 27.35 vs. BGPTX (8.93).
AEPGXBGPTXAEPGX / BGPTX
Total Expense Ratio0.850.63135%
Annual Report Gross Expense Ratio0.850.63135%
Fund Existence41 years11 years-
Gain YTD3.630-7.220-50%
Front Load6%N/A-
Min. Initial Investment250250000000%
Min. Initial Investment IRAN/AN/A-
Net Assets123B192M64,063%
Annual Yield % from dividends1.113.2135%
Returns for 1 year-1.92-6.9827%
Returns for 3 years7.48-8.29-90%
Returns for 5 years27.358.93306%
Returns for 10 years11.6019.3560%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDNA18.490.65
+3.64%
CareDx
RGEN145.233.83
+2.71%
Repligen Corp
PSEC3.670.04
+1.10%
Prospect Capital Corp
ZVSA0.720.01
+1.00%
ZyVersa Therapeutics
LGO1.63-0.01
-0.61%
Largo